Compare Adaptive Biotechnologies Corp (ADPT) vs AXT Inc (AXTI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs AXT Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while AXT Inc trades at $78.95 (market cap $4.83B). The key difference: AXT Inc is the larger of the two by market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, AXT Inc nearer its low. Which is the better fit depends on your goals.
| ADPT | AXTI | |
|---|---|---|
Market Cap | $4.04B | $4.83B |
Sector | Health | Technology |
52-Week High | $25.45 | $140.83 |
52-Week Low | $12.30 | $2.05 |
Enterprise Value | $4.10B | $4.50B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About AXT Inc
AXT develops and manufactures high-performance compound semiconductor wafer substrates. Its products, like indium phosphide and gallium arsenide, are essential for data centers, 5G, and consumer electronics.
Read more on AXTI →
